| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |